Dietary cholesterol overconsumption is not a significant health concern.

Trigger: the subclaim "A subset of people (hyper-responders) experience substantial blood cholesterol increases from dietary cholesterol intake" received its first assessment, supported (confidence 0.82, credence 0.87). It sits on the against-argument ("Responder subgroups and the LDL pathway") with a contradicts relation to the parent.

Materiality: the prior parent assessment explicitly treated this premise as "well-founded but unassessed," so its confirmation ratifies an assumption the verdict already relied on rather than adding new weight. The one qualification surfaced by the subclaim steward, that hyper-responders typically raise LDL and HDL together so the ratio is roughly unchanged, slightly softens the "substantial harm" reading for that subgroup, but does not neutralize it: the companion subclaim "Elevated LDL cholesterol causes cardiovascular disease" is verified (confidence 0.94), so a real LDL rise in a third of people remains a genuine mechanistic concern. Net effect on the parent: none to the status; the against-argument's backbone is firm.

Weighing the structure: - For-argument: "Dietary cholesterol has only a weak, variable effect on blood cholesterol" is supported (confidence 0.72), with the caveat that the effect grows in hyper-responders and at high intakes; "not consistently associated with cardiovascular disease risk in the general population" remains contested (confidence 0.86), with credible sources on both sides (2020 AHA science advisory and Berger et al. 2015 finding no significant association, versus Zhong et al. 2019 JAMA pooled cohorts finding a dose-response association). A contested central empirical premise blocks a "supported" reading of the parent. - Against-argument: LDL-causes-CVD is verified and the hyper-responder premise is now supported, jointly establishing a real concern for an identifiable subgroup.

Instance stance: the single source instance affirms only the narrow proposition ("cholesterol is not a nutrient of concern for overconsumption"). No credible instance defends the strong evaluative reading, and major bodies actively oppose it.

Verdict: CONTESTED holds. The narrow proposition (no numeric limit justified for the general population) is near-consensus; the broad evaluative proposition is contested by credible authorities and evidence. Not contradicted, because the weak-effect finding and the 2015 guideline change are real. Confidence held at 0.86. No single credence: this is an evaluative composite whose parts pull in different directions, so one probability would be false precision. What would move the verdict: robust long-term evidence on dietary cholesterol intake and hard cardiovascular endpoints in the general population.